Sam Harris

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.

Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.

Journal: Gastroenterology

Published: February 14, 2026

Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trial.

Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trial.

Journal: Journal of the National Cancer Institute

Published: November 18, 2025

Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 22, 2025

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.

Journal: Nature medicine

Published: September 05, 2025

Implementing Teletrials to Improve Equity of Access for Regional Patients With Cancer: Report From the Victorian Teletrial Collaborative.

Implementing Teletrials to Improve Equity of Access for Regional Patients With Cancer: Report From the Victorian Teletrial Collaborative.

Journal: Asia-Pacific journal of clinical oncology

Published: July 06, 2025

Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia.

Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia.

Journal: Clinical drug investigation

Published: February 15, 2025

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.

Journal: Clinical and translational science

Published: November 17, 2024

Teletrial implementation in early phase clinical trials: two national workshops.

Teletrial implementation in early phase clinical trials: two national workshops.

Journal: Trials

Published: August 16, 2024

Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial.

Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial.

Journal: Clinical and translational science

Published: May 07, 2024

Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial.

Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial.

Journal: JAMA oncology

Published: September 21, 2023

Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies.

Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies.

Journal: Acta haematologica

Published: August 20, 2023

Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.

Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.

Journal: Clinical and translational science

Published: July 14, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026